Analysis of Transcriptomic Data Generated from Drug-Treated Cancer Cell Line

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Chemotherapy resistance is a significant challenge in cancer treatment.
• Understanding the dynamic molecular changes during resistance development is vital for effective therapy.
• Next-generation omics technologies enable precise mapping of these alterations at the single-cell level.

Purpose of the Study:

• To present a detailed transcriptomic pipeline for analyzing gene expression changes during chemotherapy resistance acquisition.
• To provide a comprehensive method for tracking transcriptomic alterations and identifying key regulatory elements.

Main Methods:

• Utilizing next-generation sequencing for transcriptomic analysis.
• Implementing a pipeline to track differential gene expression.
• Applying gene ontology analysis to understand functional implications.
• Filtering for key genes and identifying regulated pathways and interactions.

Main Results:

• The pipeline enables detailed mapping of molecular alterations during chemoresistance.
• It facilitates the identification of differentially expressed transcripts, gene ontology functions, and key regulatory genes.
• The method allows for the elucidation of regulated pathways and potential gene interaction networks.

Conclusions:

• The described transcriptomic pipeline offers a robust analytical framework for studying chemoresistance.
• This approach can significantly advance research into the molecular mechanisms underlying cancer treatment failure.
• The findings support the development of targeted cancer therapies by revealing dynamic resistance mechanisms.